TY  - JOUR 
AU  - Villar-Alvarez, E.
AU  - Golán-Cancela, I.
AU  - Pardo Montero, Alberto
AU  - Velasco, B.
AU  - Fernández-Vega, J.
AU  - Cambón, A.
AU  - Al-Modlej, A.
AU  - Topete, A.
AU  - Barbosa, S.
AU  - Costoya Puente, José Antonio
AU  - Taboada Antelo, Pablo
PY  - 2023
SN  - 1613-6829
UR  - http://hdl.handle.net/20.500.11940/21644
AB  - Treatment failure in breast cancers overexpressing human epidermal growth factor receptor 2 (HER2) is associated mainly to the upregulation of human epidermal growth factor receptor 3 (HER3) oncoprotein linked to chemoresitence. Therefore, to increase...
LA  - eng
KW  - Humans
KW  - Animals
KW  - Mice
KW  - Female
KW  - Breast Neoplasms
KW  - Proto-Oncogene Proteins c-akt
KW  - Gold
KW  - Nanoshells
KW  - Receptor, ErbB-2
KW  - Doxorubicin
KW  - RNA, Small Interfering
KW  - Cell Line, Tumor
TI  - Inhibiting HER3 Hyperphosphorylation in HER2-Overexpressing Breast Cancer through Multimodal Therapy with Branched Gold Nanoshells
DO  - 10.1002/smll.202303934
T2  - Small
KW  - IDIS
KW  - IDIS
KW  - IDIS
VL  - 19
ER  -